Current Income Tax Expense (Benefit) in USD of ANAVEX LIFE SCIENCES CORP. from Q4 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Anavex Life Sciences Corp. quarterly/annual Current Income Tax Expense (Benefit) history and change rate from Q4 2015 to Q2 2024.
  • Anavex Life Sciences Corp. Current Income Tax Expense (Benefit) for the quarter ending 30 Jun 2024 was -$67K, a 263% decline year-over-year.
  • Anavex Life Sciences Corp. Current Income Tax Expense (Benefit) for the twelve months ending 30 Jun 2024 was $59K, a 79% decline year-over-year.
  • Anavex Life Sciences Corp. annual Current Income Tax Expense (Benefit) for 2023 was $7K, a 98% decline from 2022.
  • Anavex Life Sciences Corp. annual Current Income Tax Expense (Benefit) for 2022 was $358K, a 33.6% increase from 2021.
  • Anavex Life Sciences Corp. annual Current Income Tax Expense (Benefit) for 2021 was $268K, a 1082% increase from 2020.
Current Income Tax Expense (Benefit), Trailing 12 Months (USD)
Current Income Tax Expense (Benefit), Quarterly (USD)
Current Income Tax Expense (Benefit), YoY Quarterly Change (%)
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Change (%)

ANAVEX LIFE SCIENCES CORP. Quarterly Current Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $59K -$67K -$108K -263% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 $167K $105K +$55K +110% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $112K $85K +$105K 01 Oct 2023 31 Dec 2023 10-Q 07 Feb 2024
Q3 2023 $7K -$64K -$274K -131% 01 Jul 2023 30 Sep 2023 10-K 23 Dec 2024
Q2 2023 $281K $41K -$47.4K -53.6% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 $328K $50K +$20.2K +67.8% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 $308K -$20K -$50K -167% 01 Oct 2022 31 Dec 2022 10-Q 07 Feb 2024
Q3 2022 $358K $210K +$67.1K +47% 01 Jul 2022 30 Sep 2022 10-K 27 Nov 2023
Q2 2022 $291K $88.4K +$49.4K +127% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 $242K $29.8K +$2.81K +10.4% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 $239K $30K -$29.3K -49.4% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023
Q3 2021 $268K $143K +$134K +1553% 01 Jul 2021 30 Sep 2021 10-K 27 Nov 2023
Q2 2021 $134K $39K +$34.2K +710% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $99.7K $27K +$27K 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 $72.7K $59.3K +$50.1K +543% 01 Oct 2020 31 Dec 2020 10-Q 09 Feb 2022
Q3 2020 $22.7K $8.63K +$2.52K +41.2% 01 Jul 2020 30 Sep 2020 10-K 28 Nov 2022
Q2 2020 $20.1K $4.82K -$14.5K -75% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $34.6K $0 -$48K -100% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $82.7K $9.21K +$497 +5.7% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021
Q3 2019 $82.2K $6.12K 01 Jul 2019 30 Sep 2019 10-K 28 Dec 2020
Q2 2019 $19.3K 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 $48K +$20.2K +72.5% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 $8.72K -$688 -7.32% 01 Oct 2018 31 Dec 2018 10-Q 06 Feb 2020
Q1 2018 $56.3K $27.9K +$18.3K +190% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 $38K $9.41K -$21.6K -69.7% 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019
Q3 2017 $59.6K $9.13K 01 Jul 2017 30 Sep 2017 10-K 25 Jan 2019
Q2 2017 $9.88K +$3.88K +64.6% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 $9.6K 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q4 2016 $31K +$13.4K +76% 01 Oct 2016 31 Dec 2016 10-Q 07 Feb 2018
Q2 2016 $6K 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017
Q4 2015 $17.6K 01 Oct 2015 31 Dec 2015 10-Q 07 Feb 2017

ANAVEX LIFE SCIENCES CORP. Annual Current Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7K -$351K -98% 01 Oct 2022 30 Sep 2023 10-K 23 Dec 2024
2022 $358K +$90K +33.6% 01 Oct 2021 30 Sep 2022 10-K 27 Nov 2023
2021 $268K +$245K +1082% 01 Oct 2020 30 Sep 2021 10-K 27 Nov 2023
2020 $22.7K -$59.5K -72.4% 01 Oct 2019 30 Sep 2020 10-K 28 Nov 2022
2019 $82.2K +$9.44K +13% 01 Oct 2018 30 Sep 2019 10-K 28 Dec 2020
2018 $72.7K +$13.1K +22% 01 Oct 2017 30 Sep 2018 10-K 16 Dec 2019
2017 $59.6K +$30K +101% 01 Oct 2016 30 Sep 2017 10-K 25 Jan 2019
2016 $29.6K 01 Oct 2015 30 Sep 2016 10-K 25 Jan 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.